The med-tech world has not been shy about accepting the notion that
future growth will be predicated, at least in part, on good exposure to
emerging markets.
Stryker (NYSE:
SYK) is the latest to back that view with cold cash, spending $764 million to acquire Chinese orthopedics company
Trauson Holdings (OTC:
TRHDF).
Coupled with improving fundamentals in the core recon market (hip/knee
replacements), Stryker continues to look like a solid stock in the
med-tech sector.
To read more, please follow this link:
http://www.investopedia.com/stock-analysis/2013/Stryker-Follows-Its-Rivals-With-A-Big-Investment-In-China-SYK-MDT-JNJ-ZMH0122.aspx
No comments:
Post a Comment